Development of a Production Process for Stem Cell Based Cell Therapeutic Implants Using Disposable Bioreactor Systems

  • Weber C
  • Pohl S
  • Poertner R
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Cell therapy enables the treatment of various diseases like diabetes mellitus or stroke. The basis of many cell implants are mesenchymal stem cells, which have to be multiplied and harvested with high viability prior to use. For that purpose bioreactor systems are required, which allow the cultivation of the cells under GMP-conforming conditions. Here a fixed bed cultivation system for the expansion and differentiation of a hMSC production cell line on the basis of commercially available polymeric or glass syringes is introduced.

Author-supplied keywords

  • hMSC-TERT; fixed bed bioreactor; harvesting

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • C Weber

  • S Pohl

  • R Poertner

  • C Wallrapp

  • P Geigle

  • P Czermak

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free